Trial Information

Official Title: Phase 2 (Feasibility) Study of Transcranial Magnetic Stimulation as Additional Therapy to Drug Treatment in Patients With Alzheimer's Disease

Summary

The primary objective of this trial is to assess the ability of Transcranial Magnetic Stimulation with H2 coil to prefrontal and parieto-temporal cortex to improve cognitive performance in patients with Alzheimer's disease which received drug treatment. This study is a single-center, double-blind 4 months duration trial.

Phase: Phase 2

Sponsor: Tel-Aviv Sourasky Medical Center

Overall Contacts:

Alissa Ash, Dr.
+972-3-6973698
elissaa@tasmc.health.gov.il